Yoshihito Tashiro
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: August 30, 2023
The in vitro effect of anticoagulant agents on coagulation and fibrinolysis in the presence of emicizumab in the plasmas from patients with haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 05, 2023
Detailed analysis of anti-emicizumab antibody decreasing drug efficacy, using plasma samples from a patient with hemophilia A.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 30, 2021
Prolonged Duration of Erythropoiesis-Stimulating Agents' Action Delays Disease Progression in Anti-Thy 1 Antibody-Induced Chronic Glomerulonephritis Rats.
Journal: Pharmacology
Published: October 10, 2019
T2 ∗ Relaxation Time Obtained from Magnetic Resonance Imaging of the Liver Is a Useful Parameter for Use in the Construction of a Murine Model of Iron Overload.
Journal: Contrast media & molecular imaging
Published: October 15, 2018
Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease.
Journal: BMC nephrology
Published: February 13, 2017
Epoetin beta pegol ameliorates flow-mediated dilation with improving endothelial nitric oxide synthase coupling state in nonobese diabetic rats.
Journal: Cardiovascular therapeutics
Published: January 06, 2017
Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis rats.
Journal: Physiological reports
Published: December 05, 2015
Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.
Journal: International journal of hematology
Published: November 12, 2015
Eldecalcitol prevents endothelial dysfunction in postmenopausal osteoporosis model rats.
Journal: The Journal of endocrinology
Published: November 03, 2015
Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease rats.
Journal: European journal of pharmacology
Published: April 14, 2015
Renoprotective effect of epoetin beta pegol by the prevention of M2 macrophage recruitment in Thy-1 rats.
Journal: Journal of nephrology
Published: March 17, 2014
Last Updated: 09/26/2026